| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
GE KH MA MD TN |
| (30) |
Priority: |
15.12.2023 GB 202319255 10.07.2024 US 202463669394 P 06.11.2024 US 202463716754 P
|
| (71) |
Applicant: Alchemab Therapeutics Ltd. |
|
London N1C 4AX (GB) |
|
| (72) |
Inventors: |
|
- MCCARTHY, James
London, N1C 4AX (GB)
- LEGG, Sandrine
London, N1C 4AX (GB)
- LEWIS, Giles
London, N1C 4AX (GB)
- MITCHELL, Laura Sophie
London, N1C 4AX (GB)
- BARTON, Justin
London, N1C 4AX (GB)
- POVALL, Chelsea
London, N1C 4AX (GB)
- JENKINS KNIGHT, Emma Louise
London, N1C 4AX (GB)
- MINTER, Ralph Raymond
London, N1C 4AX (GB)
- FINCH, Donna
London, N1C 4AX (GB)
- SIDOR, Michelle
London, N1C 4AX (GB)
- GALSON, Jacob Daniel
London, N1C 4AX (GB)
- OSBOURN, Jane Katharine
London, N1C 4AX (GB)
- DIAS DO NASCIMENTO, Jorge Norman
London, N1C 4AX (GB)
- KOLASINSKA-ZWIERZ, Paulina Maria
London, N1C 4AX (GB)
- HAWTHORNE, William James
London, N1C 4AX (GB)
- GRAVES, Helen
London, N1C 4AX (GB)
|
| (74) |
Representative: Mewburn Ellis LLP |
|
Aurora Building
Counterslip Bristol BS1 6BX Bristol BS1 6BX (GB) |
|